Inactive Instrument

Proto Script Pharmaceutical Corp. Stock Other OTC

PSCR

US74373V1052

Valuation: Proto Script Pharmaceutical Corp.

Market Cap	1.97M 1.7M 1.59M 1.45M 2.73M 188M 2.76M 18.66M 7.31M 94.16M 7.38M 7.22M 313M	P/E 2015 *	-	P/E 2016	-41.4x
Enterprise Value	2.01M 1.74M 1.63M 1.49M 2.79M 193M 2.83M 19.12M 7.49M 96.45M 7.56M 7.4M 321M	EV / Sales 2015 *	-	EV / Sales 2016	394x
Free-Float	89.82%	Yield 2015 *	-	Yield 2016	-

* Estimated data More valuation ratios

Latest news : Proto Script Pharmaceutical Corp.

17-04-21	Proto Script Pharmaceutical Enters Partnership with PAKmed	CI
16-11-09	Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D	CI
16-11-07	Proto Script Pharmaceutical Corp. Announces Management Changes	CI
16-10-13	Yanex Group, Inc. will Change its Ticker to YNXGD from YNXG	CI
16-09-09	Yanex Group, Inc. Announces Management Changes	CI
16-09-09	Yanex Group Seeks Acquisitions	CI
16-07-05	Yanex Group, Inc. Reports Unaudited Consolidated Earnings Results for the Three Months Ended March 31, 2016	CI
16-07-04	Proto-Script Pharmaceuticals, Corp. acquired Yanex Group, Inc. in a reverse merger transaction.	CI
15-03-16	Michelle Rico acquired Proto-Script Pharmaceuticals Corp. from other stockholders.	CI
15-01-23	Proto-Script Pharmaceuticals Corp. agreed to acquire 49.29% in Wolverine Holding Corp. from Coral Capital Partners, Inc. for $0.06 million.	CI

More news

Managers and Directors: Proto Script Pharmaceutical Corp.

Manager	Title	Age	Since
Michelle Rico CEO	Chief Executive Officer	58	2016-06-28

More insiders

Other Business Support Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PROTO SCRIPT PHARMACEUTICAL CORP.	-.--%	-43.33%	-	-	11.38K
CINTAS CORPORATION	-0.85%	-2.41%	-8.65%	+63.51%	79.16B
JACOBS SOLUTIONS INC.	-0.71%	-2.51%	-2.92%	+7.99%	16.81B
BUREAU VERITAS SA	+0.22%	-2.71%	+3.02%	+12.82%	14.21B
INTERTEK GROUP PLC	+0.26%	+0.26%	+25.97%	+43.19%	12.18B
ALS LIMITED	-1.07%	-5.12%	+19.81%	+100.18%	8.12B
ISS A/S	-0.61%	+7.40%	+51.84%	+146.39%	7.11B
GENPACT LIMITED	-0.47%	-1.26%	-22.81%	-6.39%	5.66B
DKSH HOLDING AG	-1.47%	-2.90%	+16.93%	-1.33%	5.38B
EXLSERVICE HOLDINGS, INC.	-0.73%	-1.45%	-18.38%	+25.72%	5.24B
Average	-0.54%	-0.99%	+7.20%	+43.57%	17.1B
Weighted average by Cap.	-0.65%	-1.47%	+0.13%	+50.80%

See all sector performances

Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.

Employees

Sector

Business Support Services

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock markets for all

100% Free Registration

	2015	2016
Net sales	881K 761K 714K 650K 1.22M 84.28M 1.24M 8.37M 3.28M 42.22M 3.31M 3.24M 140M	789K 681K 639K 582K 1.09M 75.44M 1.11M 7.49M 2.94M 37.79M 2.96M 2.9M 126M
Net income	-145K -125K -118K -107K -201K -13.89M -204K -1.38M -540K -6.96M -545K -534K -23.14M	-7.18M -6.2M -5.82M -5.3M -9.96M -687M -10.1M -68.2M -26.72M -344M -26.97M -26.38M -1.14B
Net Debt	27.07K 23.37K 21.92K 19.97K 37.55K 2.59M 38.07K 257K 101K 1.3M 102K 99.43K 4.31M	47.78K 41.25K 38.7K 35.25K 66.28K 4.57M 67.2K 454K 178K 2.29M 179K 176K 7.61M